Erlotinib induced ectropion following papulopustular rash

Journal of Dermatological Case Reports

Andac Salman²  Dilek Seckin³  Metin Kanitez¹ 

[1] Marmara University School of Medicine, Department of Oncology, Istanbul, Turkey.Marmara University School of Medicine, Department of Ophthalmology, Istanbul, Turkey;Marmara University School of Medicine, Department of Dermatology, Istanbul, Turkey;

关键词: adverse effects;    ectropion;    eye;    erlotinib;    papulopustular rash;   

DOI  :  10.3315/jdcr.2015.1203

学科分类：皮肤病学

来源: Specjalisci Dermatolodz

【 摘 要 】

Erlotinib is a targeted anti-cancer drug which acts through the inhibition of epidermal growth factor receptor (EGFR).

【 授权许可】

Unknown